RxDoctor Payments Data

Meredith Kent

Medical · Grand Rapids, MINPI 1790986917

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $174,259 of the $192,433 with a category attached, or 90.6%. Galderma Laboratories, L.p. accounts for 60.5% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2021 at $107,133 and has fallen 93.6% since, to $6,887 in 2025. Among medical clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$192,433in general payments, 2019–2025

Across 358 payments — averaging $537.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Galderma Laboratories, L.p.$116K
  • AbbVie$76K
  • Revance Therapeutics, Inc.$64

What the payments were for

  • Consulting fees$5000%
  • Speaking & faculty fees$174,25991%
  • Travel & lodging$13,6747%
  • Food & beverage$3,9802%
  • Education$200%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Galderma Laboratories, L.p.210$116,352
AbbVie(2 entities)144$76,017
Revance Therapeutics, Inc.4$64

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$192,433 in reported general payments places this provider in the 95th percentile of 755 medical providers in Michigan.

See all medical providers in Michigan

Other medical in Grand Rapids

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →